The genus Prevotella in cystic fibrosis airways

Anaerobe

Volumn 16, Issue 4, 2010, Pages 337-344

  Field, Tyler R ^a   Sibley, Christopher D ^a   Parkins, Michael D ^a,b   Rabin, Harvey R ^a,b   Surette, Michael G ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cystic fibrosis; Polymicrobial infections; Prevotella; Pulmonary infection; Sputum

Indexed keywords

AUTOINDUCER 2; BACTERIAL PROTEIN; BETA LACTAMASE; RNA 16S; UNCLASSIFIED DRUG;

ANAEROBIC BACTERIUM; ANAEROBIC CELL CULTURE; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYSTIC FIBROSIS; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREVOTELLA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RNA SEQUENCE; SPECIES DIVERSITY; SPUTUM;

ADULT; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CLUSTER ANALYSIS; COLONY COUNT, MICROBIAL; CYSTIC FIBROSIS; DNA, BACTERIAL; DNA, RIBOSOMAL; HOMOSERINE; HUMANS; LACTONES; PREVOTELLA; RESPIRATORY SYSTEM; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID; SPUTUM;

BACTERIA (MICROORGANISMS); PREVOTELLA;

EID: 77956059369     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2010.04.002     Document Type: Article

References (38)

1. Boucher R.C. An overview of the pathogenesis of cystic fibrosis lung disease. Adv Drug Deliv Rev 2002, 54(11):1359-1371.
2. Gilligan P.H. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991, 4(1):35-51.
3. Sibley C.D., Rabin H., Surette M.G. Cystic fibrosis: a polymicrobial infectious disease. Future Microbiol 2006, 1:53-61.
4. Rogers G.B., Carroll M.P., Bruce K.D. Studying bacterial infections through culture-independent approaches. J Med Microbiol 2009, 58(Pt 11):1401-1418.
5. Sibley C.D., Parkins M.D., Rabin H., Surette M.G. The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis. Curr Opin Investig Drugs 2009.
6. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekici A., Meyer K.C., et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 2002, 109(3):317-325.
7. Tunney M.M., Field T.R., Moriarty T.F., Patrick S., Doering G., Muhlebach M.S., et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 2008, 177(9):995-1001.
8. Worlitzsch D., Rintelen C., Bohm K., Wollschlager B., Merkel N., Borneff-Lipp M., et al. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. Clin Microbiol Infect 2009, 15(5):454-460.
9. Harris J.K., De Groote M.A., Sagel S.D., Zemanick E.T., Kapsner R., Penvari C., et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci USA 2007, 104(51):20529-20533.
10. Rogers G.B., Hart C.A., Mason J.R., Hughes M., Walshaw M.J., Bruce K.D. Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 2003, 41(8):3548-3558.
11. Rogers G.B., Carroll M.P., Serisier D.J., Hockey P.M., Jones G., Bruce K.D. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 2004, 42(11):5176-5183.
12. Rogers G.B., Carroll M.P., Serisier D.J., Hockey P.M., Jones G., Kehagia V., et al. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. J Clin Microbiol 2006, 44(7):2601-2604.
13. Bittar F., Richet H., Dubus J.C., Reynaud-Gaubert M., Stremler N., Sarles J., et al. Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. PLoS One 2008, 3(8):e2908.
14. Armougom F., Bittar F., Stremler N., Rolain J.M., Robert C., Dubus J.C., et al. Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing. Eur J Clin Microbiol Infect Dis 2009.
15. Bacteroides, Porphyromonas, Prevotella, Fusobacterium, and other anaerobic gram-negative bacteria 2003, American Society for Microbiology, Washington DC. 6th ed. H.R. Jousimies-Somer, P.H. Summanen, H. Wexler, S.M. Finegold, S.E. Gharbia, H.N. Shah (Eds.).
16. Martin F.E., Nadkarni M.A., Jacques N.A., Hunter N. Quantitative microbiological study of human carious dentine by culture and real-time PCR: association of anaerobes with histopathological changes in chronic pulpitis. J Clin Microbiol 2002, 40(5):1698-1704.
17. Paster B.J., Boches S.K., Galvin J.L., Ericson R.E., Lau C.N., Levanos V.A., et al. Bacterial diversity in human subgingival plaque. J Bacteriol 2001, 183(12):3770-3783.
18. Al Masalma M., Armougom F., Scheld W.M., Dufour H., Roche P.H., Drancourt M., et al. The expansion of the microbiological spectrum of brain abscesses with use of multiple 16S ribosomal DNA sequencing. Clin Infect Dis 2009, 48(9):1169-1178.
19. Nadkarni M.A., Caldon C.E., Chhour K.L., Fisher I.P., Martin F.E., Jacques N.A., et al. Carious dentine provides a habitat for a complex array of novel Prevotella-like bacteria. J Clin Microbiol 2004, 42(11):5238-5244.
20. Downes J., Hooper S.J., Wilson M.J., Wade W.G. Prevotella histicola sp. nov., isolated from the human oral cavity. Int J Syst Evol Microbiol 2008, 58(Pt 8):1788-1791.
21. Dewhirst F.E., Izard J., Paster B.J., Tanner A.C., Wade W.G., Yu W.-H., et al. The human oral microbiome database Available from:. http://www.homd.org.
22. Kazor C.E., Mitchell P.M., Lee A.M., Stokes L.N., Loesche W.J., Dewhirst F.E., et al. Diversity of bacterial populations on the tongue dorsa of patients with halitosis and healthy patients. J Clin Microbiol 2003, 41(2):558-563.
23. Sibley C.D., Parkins M.D., Rabin H.R., Duan K., Norgaard J.C., Surette M.G. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci USA 2008, 105(39):15070-15075.
24. Liu W.T., Marsh T.L., Cheng H., Forney L.J. Characterization of microbial diversity by determining terminal restriction fragment length polymorphisms of genes encoding 16S rRNA. Appl Environ Microbiol 1997, 63(11):4516-4522.
25. Cole J.R., Chai B., Farris R.J., Wang Q., Kulam-Syed-Mohideen A.S., McGarrell D.M., et al. The ribosomal database project (RDP-II): introducing myRDP space and quality controlled public data. Nucleic Acids Res 2007, 35(Database issue):D169-D172.
26. Cole J.R., Wang Q., Cardenas E., Fish J., Chai B., Farris R.J., et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 2009, 37(Database issue):D141-D145.
27. Beeston A.L., Surette M.G. pfs-dependent regulation of autoinducer 2 production in Salmonella enterica serovar Typhimurium. J Bacteriol 2002, 184(13):3450-3456.
28. DeSantis T.Z., Hugenholtz P., Keller K., Brodie E.L., Larsen N., Piceno Y.M., et al. NAST: a multiple sequence alignment server for comparative analysis of 16S rRNA genes. Nucleic Acids Res 2006, 34(Web Server issue):W394-W399.
29. Saitou N., Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987, 4(4):406-425.
30. Felsenstein D., Carney W.P., Iacoviello V.R., Hirsch M.S. Phenotypic properties of atypical lymphocytes in cytomegalovirus-induced mononucleosis. J Infect Dis 1985, 152(1):198-203.
31. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24(8):1596-1599.
32. Matto J., Asikainen S., Vaisanen M.L., Von Troil-Linden B., Kononen E., Saarela M., et al. Beta-lactamase production in Prevotella intermedia, Prevotella nigrescens, and Prevotella pallens genotypes and in vitro susceptibilities to selected antimicrobial agents. Antimicrob Agents Chemother 1999, 43(10):2383-2388.
33. Duan K., Dammel C., Stein J., Rabin H., Surette M.G. Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol 2003, 50(5):1477-1491.
34. Parkins M.D., Sibley C.D., Surette M.G., Rabin H.R. The Streptococcus milleri group-an unrecognized cause of disease in cystic fibrosis: a case series and literature review. Pediatr Pulmonol 2008, 43(5):490-497.
35. Aas J.A., Paster B.J., Stokes L.N., Olsen I., Dewhirst F.E. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005, 43(11):5721-5732.
36. Barth A.L., Pitt T.L. Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J Clin Microbiol 1995, 33(1):37-40.
37. Thomas S.R., Ray A., Hodson M.E., Pitt T.L. Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax 2000, 55(9):795-797.
38. Shinzato T., Saito A. A mechanism of pathogenicity of " Streptococcus milleri group" in pulmonary infection: synergy with an anaerobe. J Med Microbiol 1994, 40(2):118-123.